Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.
- DOI
- 10.1016/s0140-6736(16)00082-9
- Published
- 2016 Mar 19
- Container
- Lancet (London, England)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0140-6736-16-00082-9,
title = {Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.},
author = {Greenberg B and Butler J and Felker GM and Ponikowski P and Voors AA and Desai AS and Barnard D and Bouchard A and Jaski B and Lyon AR and Pogoda JM and Rudy JJ and Zsebo KM},
year = {2016},
journal = {Lancet (London, England)},
doi = {10.1016/s0140-6736(16)00082-9},
url = {https://doi.org/10.1016/s0140-6736(16)00082-9}
}RIS
TY - JOUR TI - Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial. AU - Greenberg B AU - Butler J AU - Felker GM AU - Ponikowski P AU - Voors AA AU - Desai AS AU - Barnard D AU - Bouchard A AU - Jaski B AU - Lyon AR AU - Pogoda JM AU - Rudy JJ AU - Zsebo KM PY - 2016 JO - Lancet (London, England) DO - 10.1016/s0140-6736(16)00082-9 UR - https://doi.org/10.1016/s0140-6736(16)00082-9 ER -
APA
B, G., J, B., GM, F., P, P., AA, V., AS, D., D, B., A, B., B, J., AR, L., JM, P., JJ, R., & KM, Z. (2016). Calcium upregulation by percutaneous administration of gene therapy in patients with cardiac disease (CUPID 2): a randomised, multinational, double-blind, placebo-controlled, phase 2b trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(16)00082-9
Source records
- pubmed · retrieved 2026-09-26T04:23:40.955Z